Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

Low-income Pennsylvanians could lose access to medical coverage for popular weight-loss drugs like Ozempic and Wegovy as ...

House of Delegates today passed the Endocrine Society's resolution to improve access to anti-obesity medications.

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

California's proposed budget cuts to Medicaid/Medi-Cal could exacerbate the obesity crisis, particularly in Black and Brown ...

Pursuing the worthy goal of reforming drug pricing requires a more radical change to the pharmaceutical industry.

China, which makes the overwhelming number of polysilicate panels, also happens to be a strategic competitor against the West ...

The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.

The National Council on Aging (NCOA), the national voice for every person's right to age well, applauds today's ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...